Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Capital Expenditures: 2016-2024

Historic Capital Expenditures for Arcus Biosciences (RCUS) over the last 9 years, with Dec 2024 value amounting to $6.0 million.

  • Arcus Biosciences' Capital Expenditures fell 75.00% to $1.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $7.0 million, marking a year-over-year decrease of 70.83%. This contributed to the annual value of $6.0 million for FY2024, which is 75.00% down from last year.
  • As of FY2024, Arcus Biosciences' Capital Expenditures stood at $6.0 million, which was down 75.00% from $24.0 million recorded in FY2023.
  • Arcus Biosciences' Capital Expenditures' 5-year high stood at $26.0 million during FY2021, with a 5-year trough of $3.0 million in FY2020.
  • Moreover, its 3-year median value for Capital Expenditures was $6.0 million (2024), whereas its average is $12.0 million.
  • As far as peak fluctuations go, Arcus Biosciences' Capital Expenditures spiked by 766.67% in 2021, and later crashed by 76.92% in 2022.
  • Over the past 5 years, Arcus Biosciences' Capital Expenditures (Yearly) stood at $3.0 million in 2020, then surged by 766.67% to $26.0 million in 2021, then slumped by 76.92% to $6.0 million in 2022, then soared by 300.00% to $24.0 million in 2023, then slumped by 75.00% to $6.0 million in 2024.